Article
Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line.
The Journal of urology - 1 Sept 1996
Eastham J A, Ahlering T E
Abstract excerpt
PURPOSE: In this study, we evaluated the ability of a ribozyme (catalytic RNA), which site specifically cleaves the mRNA of the activated H-ras gene, to alter the malignant phenotype of an invasive human bladder cancer cell line. MATERIALS AND METHODS: The human bladder cancer cell line EJ which contains the activated H-ras gene was used in these studies. Cell lines with and without the anti-ras ribozyme were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
